# Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden

> **NCT04910802** · PHASE4 · RECRUITING · sponsor: **Miriam Elfström** · enrollment: 150000 (estimated)

## Conditions studied

- HPV Infection
- CIN 2/3
- Cervical Cancer

## Interventions

- **BIOLOGICAL:** Gardasil9

## Key facts

- **NCT ID:** NCT04910802
- **Lead sponsor:** Miriam Elfström
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-05-03
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 150000 (ESTIMATED)
- **Last updated:** 2021-09-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04910802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04910802, "Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04910802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*